Analysis of surgical stage lung cancer and tumour markers prognostic value

A. Rego, A. Oliveira, A. Barroso, S. Conde, A. Lira, J. Miranda, F. Leal, B. Parente (Vila Nova de Gaia, Portugal)

Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Session: Biological features, lung function and treatment of lung cancer
Session type: Electronic Poster Discussion
Number: 4428
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Rego, A. Oliveira, A. Barroso, S. Conde, A. Lira, J. Miranda, F. Leal, B. Parente (Vila Nova de Gaia, Portugal). Analysis of surgical stage lung cancer and tumour markers prognostic value. Eur Respir J 2006; 28: Suppl. 50, 4428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 74s
Year: 2002

Identification of genes with diagnostic and prognostic value in lung cancer.
Source: International Congress 2019 – Biology of lung cancer
Year: 2019


The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Contribution of tumor markers to pretreatment staging of operable lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003

Time in lung cancer diagnosis and its prognostic implication
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010

The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Prognostic relevance of the new lung cancer classification in operable stages
Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Year: 2014



Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012

Prognostic value of microRNAs profiling in early stage squamous cell lung cancer
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009

Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011



The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011


Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013